Severity and clinical outcome after percutanous mitral valve repair in primary and secondary mitral regurgitation

Back

HFA Premium Access

Severity and clinical outcome after percutanous mitral valve repair in primary and secondary mitral regurgitation

Session: Valvular Heart Disease and Interventional Cardiology

Topic: Mitral Valve Intervention

Speaker: Miss D. Arslanoglu (Munich, DE)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Miss Dilba Arslanoglu

Deutsches Herzzentrum Muenchen Technical University of Munich, Munich (Germany)

0 follower

8 more presentations in this session

2-year outcomes for transcatheter repair in patients with functional mitral regurgitation from the CLASP study

Speaker: Doctor P. Kourkoveli (Maroussi-Athens, GR)

Impact of mitral regurgitation in patients with worsening heart failure: Insights from BIOSTAT-CHF.

Speaker: Doctor M. Pagnesi (Brescia, IT)

Prevalence and determinants of right ventricular dysfunction in patients with severe symptomatic high-gradient aortic stenosis

Speaker: Doctor S. Maltes (Lisbon, PT)

Gender disparities in percutaneous mitral valve repair

Speaker: Professor I. Oh (Pforzheim, DE)

Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry

Speaker: Doctor M. Pelliccia (Tivoli, IT)

Access the full session

Valvular Heart Disease and Interventional Cardiology

Speakers: Miss D. Arslanoglu, Doctor P. Kourkoveli, Doctor M. Pagnesi, Doctor S. Maltes, Professor I. Oh...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources